$3.720
+0.051 (+1.36%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Bicycle Therapeutics PLC (BCYC) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting BCYC is Buy.
Bicycle Therapeutics PLC (BCYC) 20-Day simple moving average is 3.67, while Bicycle Therapeutics PLC (BCYC) share price is $—, making it Buy.
Bicycle Therapeutics PLC (BCYC) 60-Day simple moving average is 3.85, while Bicycle Therapeutics PLC (BCYC) share price is $—, making it Sell.
Technical Analysis for BCYC
AI Technical BCYCAs of 2026-11-03, the technical board for Bicycle Therapeutics PLC (BCYC) reads buy: 5 indicators are flashing buy, 4 are indicating sell, and 4 are neutral. Price at $3.72 sits below the 60-day and 200-day moving averages and above the 5-day, 10-day and 20-day.
Momentum readings: RSI stands at 50.612, MACD stands at -0.0149 (Sell), Stochastic %K stands at 35.862, Stochastic %D stands at 36.322 and CCI stands at 33.175.
BCYC trades below the 60-day SMA (3.85) and below the 200-day SMA (4.52). Immediate resistance sits at Classic R1 4.08, then R2 4.47. Support sits at Classic S1 3.36, then S2 3.03.
Bicycle Therapeutics PLC (BCYC) Support & Resistance Level
Bicycle Therapeutics PLC (BCYC) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 50.612 |
| STOCHk_14_3_3 | 35.862 |
| STOCHd_14_3_3 | 36.322 |
| CCI_20 | 33.175 |
| AO_5_34 | 0.044 |
| MOM_10 | 0.150 |
| MACD_12_26_9 | -0.015 |
Bicycle Therapeutics PLC (BCYC) Relative Strength Index (RSI_14) is 50.612, creating a Neutral signal.
Bicycle Therapeutics PLC (BCYC) Stochastic %K is 35.862, creating a Neutral signal.
Bicycle Therapeutics PLC (BCYC) Stochastic %D is 36.322, creating a Neutral signal.
Bicycle Therapeutics PLC (BCYC) CCI_20 is 33.175, creating a Neutral signal.
Bicycle Therapeutics PLC (BCYC) Awesome Oscillator (AO) is 0.044, creating a Buy signal.
Bicycle Therapeutics PLC (BCYC) Momentum (MOM) is 0.150, creating a Buy signal.
Bicycle Therapeutics PLC (BCYC) Moving Average Convergence Divergence (MACD) is -0.015, creating a Sell signal.
Bicycle Therapeutics PLC (BCYC) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 3.698 | Buy |
| MA_10 | 3.699 | Buy |
| MA_20 | 3.670 | Buy |
| MA_60 | 3.851 | Sell |
| MA_200 | 4.521 | Sell |
| MA_250 | 4.982 | Sell |
Bicycle Therapeutics PLC (BCYC) 5-Day simple moving average is 3.698, while Bicycle Therapeutics PLC (BCYC) share price is $, making it a Buy.
Bicycle Therapeutics PLC (BCYC) 10-Day simple moving average is 3.699, while Bicycle Therapeutics PLC (BCYC) share price is $, making it a Buy.
Bicycle Therapeutics PLC (BCYC) 20-Day simple moving average is 3.670, while Bicycle Therapeutics PLC (BCYC) share price is $, making it a Buy.
Bicycle Therapeutics PLC (BCYC) 60-Day simple moving average is 3.851, while Bicycle Therapeutics PLC (BCYC) share price is $, making it a Sell.
Bicycle Therapeutics PLC (BCYC) 200-Day simple moving average is 4.521, while Bicycle Therapeutics PLC (BCYC) share price is $, making it a Sell.
Bicycle Therapeutics PLC (BCYC) 250-Day simple moving average is 4.982, while Bicycle Therapeutics PLC (BCYC) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.